DSPE-PEG5000-NHS
Based on 1 Customer Validation
DSPE-PEG5000-NHS is a PEG-modified phospholipid derivative that can be used to prepare liposomes. DSPE-PEG5000-NHS is commonly employed as a linker molecule for the surface modification of liposomes to confer targeting capabilities. DSPE-PEG5000-NHS can be used in the study of drug delivery.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 80.0%
- 분자량:5000 (Average)
-
보관:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
DSPE-PEG5000-NHS is an amphiphilic polymer containing DSPE, PEG, and NHS groups. DSPE-PEG5000-NHS exhibits biocompatibility and low toxicity, and is commonly used for drug modification[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Appearance Solid
-
분자량 5000 (Average)
-
Color White to off-white
-
SMILES
CCCCCCCCCCCCCCCCCC(OC[C@@H](OC(CCCCCCCCCCCCCCCCC)=O)COP(OCCNC(OCCNC(CCC(ON1C(CCC1=O)=O)=O)=O)=O)(O)=O)=O.[n]
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
용액&용해도
Ethanol : 20 mg/mL (Need ultrasonic)
순도&문서
-
Data Sheet (264 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Zhao W, et al. DSPE-PEG Modification of α-Conotoxin TxID. Mar Drugs. 2019 Jun 8;17(6):342. [Content Brief]
[2]. Di Wu, et al. Fluorescence imaging-guided multifunctional liposomes for tumor-specific phototherapy for laryngeal carcinoma. Biomater Sci. 2020 Jun 21;8(12):3443-3453. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)